dexmedetomidine has been researched along with nifedipine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ferguson, TB; Johnson, FK; Johnson, RA; Joshi, MS; Lancaster, JR; Parthasarathy, S | 1 |
1 review(s) available for dexmedetomidine and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dexmedetomidine and nifedipine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells.
Topics: Adrenergic alpha-Antagonists; Agmatine; Aniline Compounds; Arginine; Calcium; Calcium Channel Blockers; Cell Culture Techniques; Cells, Cultured; Culture Media, Serum-Free; Dexmedetomidine; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Estrenes; Fluorescent Dyes; Humans; Idazoxan; Imidazolines; Lipopolysaccharides; Molecular Structure; NG-Nitroarginine Methyl Ester; Nifedipine; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Pyrrolidinones; Receptors, Adrenergic, alpha-2; Second Messenger Systems; Type C Phospholipases; Umbilical Veins; Virulence Factors, Bordetella; Xanthenes; Yohimbine | 2007 |